0001209191-20-028797.txt : 20200513
0001209191-20-028797.hdr.sgml : 20200513
20200513161855
ACCESSION NUMBER: 0001209191-20-028797
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200511
FILED AS OF DATE: 20200513
DATE AS OF CHANGE: 20200513
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Parini Michael
CENTRAL INDEX KEY: 0001661567
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 20873404
MAIL ADDRESS:
STREET 1: C/O VERTEX PHARMACEUTICALS, INC.
STREET 2: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
BUSINESS PHONE: 6173416393
MAIL ADDRESS:
STREET 1: 50 NORTHERN AVENUE
CITY: BOSTON
STATE: MA
ZIP: 02210
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-05-11
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001661567
Parini Michael
C/O VERTEX PHARMACEUTICALS INCORPORATED
50 NORTHERN AVENUE
BOSTON
MA
02210
0
1
0
0
EVP, Chief Adm, Leg & BD Off
Common Stock
2020-05-11
4
M
0
1304
187.53
A
28142
D
Common Stock
2020-05-11
4
S
0
1304
286.00
D
26838
D
Stock Option (Right to Buy)
187.53
2020-05-11
4
M
0
1304
0.00
D
2029-02-05
Common Stock
1304
14338
D
Transaction made pursuant to Mr. Parini's company-approved trading plan under Rule 10b5-1.
The option vests in 16 quarterly installments from 02/06/2019.
/s/ Sabrina Yohai, Attorney-in-Fact
2020-05-13